Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2023 Filed Feb 18, 2023 00:20 UTC |
Stewart Christopher P.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 490,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001209191-23-010918 · doc4.xml · derivative · entry 2 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 Underlying: Common Stock · 490,000 shares Expires 2033-02-14 F3 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2023 Filed Feb 18, 2023 00:20 UTC |
Stewart Christopher P.Chief Financial Officer
|
GrantCommon Stock | 105,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010918 · doc4.xml · nonDerivative · entry 1 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,373 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan. F2 · balance_after: Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:55 UTC |
Linney YvonneDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001411690-22-000023 · wf-form4_166077329973010.xml · derivative · entry 3 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,923 Underlying: Common Stock · 20,000 shares Expires 2030-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:55 UTC |
Linney YvonneDirector
|
SaleCommon Stock | 20,000 | $3.62 | $72,402.00 |
DisclosureSEC source: 0001411690-22-000023 · wf-form4_166077329973010.xml · nonDerivative · entry 2 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:55 UTC |
Linney YvonneDirector
|
Exercise / conversionCommon Stock | 20,000 | $0.38 | $7,600.00 |
DisclosureSEC source: 0001411690-22-000023 · wf-form4_166077329973010.xml · nonDerivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:51 UTC |
BARKER DAVID LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 44,470 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001411690-22-000016 · wf-form4_165757265259092.xml · derivative · entry 2 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,470 shares Expires 2030-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares vested in equal monthly installments over a one year period such that the option became fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). F2 · derivative.expiration_date: The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:51 UTC |
BARKER DAVID LDirector
|
Exercise / conversionCommon Stock | 44,470 | $0.51 | $22,679.70 |
DisclosureSEC source: 0001411690-22-000016 · wf-form4_165757265259092.xml · nonDerivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 16:28 UTC |
Wong Vincent Jung-FaiDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036318 · doc4.xml · derivative · entry 1 Wong Vincent Jung-Fai · CIK 0001898723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 16:32 UTC |
Mamuszka HannahDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036328 · doc4.xml · derivative · entry 1 Mamuszka Hannah · CIK 0001810929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:30 UTC |
Linney YvonneDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036323 · doc4.xml · derivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:33 UTC |
Rajkovic AleksandarDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036330 · doc4.xml · derivative · entry 1 Rajkovic Aleksandar · CIK 0001909592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:29 UTC |
BARKER DAVID LDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036320 · doc4.xml · derivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:31 UTC |
Luderer AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036326 · doc4.xml · derivative · entry 1 Luderer Albert · CIK 0001746822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:27 UTC |
Vuori Kristiina MDDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036316 · doc4.xml · derivative · entry 1 Vuori Kristiina MD · CIK 0001612627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:26 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option (right to buy) · Derivative | 164,422 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001209191-22-036311 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,422 Underlying: Common Stock · 164,422 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| May 16, 2022 Filed May 18, 2022 20:16 UTC |
BARKER DAVID LDirector
|
PurchaseCommon Stock | 10,000 | $1.60 | $16,000.00 |
DisclosureSEC source: 0001209191-22-030026 · doc4.xml · nonDerivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,894 Read SEC document |
| May 13, 2022 Filed May 17, 2022 01:31 UTC |
Stewart Christopher P.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001209191-22-029459 · doc4.xml · derivative · entry 2 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,500 Underlying: Common Stock · 60,000 shares Expires 2030-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person. Read SEC document |
| May 13, 2022 Filed May 17, 2022 01:31 UTC |
Stewart Christopher P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 60,000 | $0.56 | $33,600.00 |
DisclosureSEC source: 0001209191-22-029459 · doc4.xml · nonDerivative · entry 1 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021. Read SEC document |
| May 12, 2022 Filed May 17, 2022 01:23 UTC |
Holmlin R. ErikDirector · President and CEO
|
Tax withholdingCommon Stock | 50,141 | $1.41 | $70,698.81 |
DisclosureSEC source: 0001209191-22-029457 · doc4.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,556 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 50,141 shares of common stock that vested on May 12, 2022 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: Includes 1,804 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 1,702 shares acquired under the ESPP on December 10, 2021. Read SEC document |
| May 12, 2022 Filed May 17, 2022 01:27 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
Tax withholdingCommon Stock | 41,496 | $1.41 | $58,509.36 |
DisclosureSEC source: 0001209191-22-029458 · doc4.xml · nonDerivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,669 F1 · kind: The reporting person is reporting the withholding by the Issuer of an aggregate of 41,496 shares of common stock that vested on May 12, 2022 pursuant to an RSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. F2 · balance_after: Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 23:31 UTC |
Rajkovic AleksandarDirector
|
GrantStock Option (right to buy) · Derivative | 194,986 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001209191-22-011920 · doc4.xml · derivative · entry 1 Rajkovic Aleksandar · CIK 0001909592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,986 Underlying: Common Stock · 194,986 shares Expires 2032-02-17 F1 · derivative.exercise_date: The shares vest in equal monthly installments over a three year period such that the option is fully vested on February 17, 2025, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). Read SEC document |
| February 15, 2022 Filed Feb 15, 2022 21:09 UTC |
Shippy RichardChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 550,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010056 · doc4.xml · derivative · entry 1 Shippy Richard · CIK 0001864622 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 02:08 UTC |
Stewart Christopher P.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 550,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010054 · doc4.xml · derivative · entry 1 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 02:10 UTC |
Shams SoheilChief Informatics Officer
|
GrantStock Option (Right to Buy) · Derivative | 550,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010057 · doc4.xml · derivative · entry 1 Shams Soheil · CIK 0001888376 · Chief Informatics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 02:07 UTC |
Chaubey AlkaChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 550,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010052 · doc4.xml · derivative · entry 1 Chaubey Alka · CIK 0001821605 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 02:06 UTC |
OLDAKOWSKI MARKChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 650,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010048 · doc4.xml · derivative · entry 1 OLDAKOWSKI MARK · CIK 0001745566 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 02:05 UTC |
Holmlin R. ErikDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 1,400,000 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-22-010044 · doc4.xml · derivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,000 Underlying: Common Stock · 1,400,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. Read SEC document |
| December 30, 2021 Filed Feb 11, 2022 23:05 UTC |
Shams SoheilChief Informatics Officer
|
GiftCommon Stock | 318,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-008977 · doc5.xml · nonDerivative · entry 1 Shams Soheil · CIK 0001888376 · Chief Informatics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,006,479 Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 17:29 UTC |
Wong Vincent Jung-FaiDirector
|
GrantStock Option (Right to Buy) · Derivative | 122,054 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0001209191-21-071120 · doc4.xml · derivative · entry 1 Wong Vincent Jung-Fai · CIK 0001898723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,054 Underlying: Common Stock · 122,054 shares Expires 2031-12-20 F1 · derivative.exercise_date: The shares vest in equal monthly installments over a three year period such that the option is fully vested on December 21, 2024, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan). Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 11:00 UTC |
Holmlin R. ErikDirector · President and CEO
|
PurchaseCommon Stock | 150 | $3.98 | $597.00 |
DisclosureSEC source: 0001209191-21-067229 · doc4.xml · nonDerivative · entry 3 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Robert Erik Holmlin Traditional IRA Disclosed balance after: 5,025 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 11:00 UTC |
Holmlin R. ErikDirector · President and CEO
|
PurchaseCommon Stock | 2,675 | $3.99 | $10,673.25 |
DisclosureSEC source: 0001209191-21-067229 · doc4.xml · nonDerivative · entry 2 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Robert Erik Holmlin Traditional IRA Disclosed balance after: 4,875 Read SEC document |
| November 29, 2021 Filed Dec 1, 2021 11:00 UTC |
Holmlin R. ErikDirector · President and CEO
|
PurchaseCommon Stock | 2,200 | $3.99 | $8,767.00 |
DisclosureSEC source: 0001209191-21-067229 · doc4.xml · nonDerivative · entry 1 Holmlin R. Erik · CIK 0001579988 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Robert Erik Holmlin Traditional IRA Disclosed balance after: 2,200 Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 11:00 UTC |
Stewart Christopher P.Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001209191-21-066283 · doc4.xml · derivative · entry 2 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,500 Underlying: Common Stock · 22,500 shares Expires 2030-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 11:00 UTC |
Stewart Christopher P.Chief Financial Officer
|
Exercise / conversionCommon Stock | 22,500 | $0.56 | $12,600.00 |
DisclosureSEC source: 0001209191-21-066283 · doc4.xml · nonDerivative · entry 1 Stewart Christopher P. · CIK 0001822991 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 22:08 UTC |
Shams SoheilChief Informatics Officer
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $5.40 | $0.00 |
DisclosureSEC source: 0001209191-21-062493 · doc4.xml · derivative · entry 1 Shams Soheil · CIK 0001888376 · Chief Informatics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on October 18, 2022, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from October 18, 2022, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 21:56 UTC |
Shams SoheilChief Informatics Officer
|
GrantCommon Stock | 5,325,378 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-061176 · doc4.xml · nonDerivative · entry 1 Shams Soheil · CIK 0001888376 · Chief Informatics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,325,378 F1 · shares: Of which 5,006,479 shares (the "Restricted Shares") are subject to a Stock Restriction Agreement, dated October 8, 2021, by and between the Issuer and Soheil Shams (the Restriction Agreement") and vest as follows: one-third of the Restricted Shares will vest on October 18, 2022 and one-twelfth of the Restricted Shares shall vest every three months following October 18, 2022, in each case subject to Dr. Shams' continuous Service (as defined in the Restriction Agreement). The number of shares that vest upon each vesting date shall be rounded down to the nearest whole share, with the balance of any shares that did not vest as a result of such rounding to vest on the final vesting date, subject to rounding. The unvested shares are subject to adjustment pursuant to the terms of the Merger Agreement (as defined below) and accelerate upon a termination in Service, subject to certain conditions. F2 · price: On October 18, 2021, the Issuer completed its previously announced acquisition (the "Acquisition") of BioDiscovery, Inc. ("BioDiscovery"), as contemplated by that certain Agreement and Plan of Merger, dated as of October 8, 2021 (the "Merger Agreement"), by and among the Issuer, Starship Merger Sub I, Inc., Starship Merger Sub II, LLC, BioDiscovery and Soheil Shams, solely in his capacity as the securityholders' representative. Pursuant to the Acquisition, all outstanding shares of BioDiscovery common stock, no par value, held by Dr. Shams were automatically cancelled and converted into the right to receive (i) cash consideration and (ii) shares of Issuer common stock, $0.0001 par value per share, as specified in the Merger Agreement. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:18 UTC |
Linney YvonneDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052584 · doc4.xml · derivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 17:20 UTC |
Mamuszka HannahDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052586 · doc4.xml · derivative · entry 1 Mamuszka Hannah · CIK 0001810929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:49 UTC |
BARKER DAVID LDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052603 · doc4.xml · derivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:48 UTC |
Luderer AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052602 · doc4.xml · derivative · entry 1 Luderer Albert · CIK 0001746822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:47 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052601 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:47 UTC |
Vuori Kristiina MDDirector
|
GrantStock Option (right to buy) · Derivative | 40,751 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-21-052600 · doc4.xml · derivative · entry 1 Vuori Kristiina MD · CIK 0001612627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,751 Underlying: Common Stock · 40,751 shares Expires 2031-08-17 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following June 10, 2021, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 15, 2021 Filed Jun 15, 2021 21:21 UTC |
Shippy RichardChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $7.37 | $0.00 |
DisclosureSEC source: 0001209191-21-040798 · doc4.xml · derivative · entry 1 Shippy Richard · CIK 0001864622 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-06-15 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on June 14, 2022, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from June 14, 2022, subject to Reporting Person's Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) through each such applicable vesting date and the terms of the Company's 2018 Equity Incentive Plan. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:12 UTC |
Linney YvonneDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040393 · doc4.xml · derivative · entry 1 Linney Yvonne · CIK 0001810930 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 19:16 UTC |
Mamuszka HannahDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040404 · doc4.xml · derivative · entry 1 Mamuszka Hannah · CIK 0001810929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:19 UTC |
BARKER DAVID LDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040409 · doc4.xml · derivative · entry 1 BARKER DAVID L · CIK 0001189124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:17 UTC |
TWOMEY CHRISTOPHER JDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040406 · doc4.xml · derivative · entry 1 TWOMEY CHRISTOPHER J · CIK 0001238935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:13 UTC |
Luderer AlbertDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040398 · doc4.xml · derivative · entry 1 Luderer Albert · CIK 0001746822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 23:10 UTC |
Vuori Kristiina MDDirector
|
GrantStock Option (right to buy) · Derivative | 7,528 | $0.00 Strike: $7.64 | $0.00 |
DisclosureSEC source: 0001209191-21-040389 · doc4.xml · derivative · entry 1 Vuori Kristiina MD · CIK 0001612627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Underlying: Common Stock · 7,528 shares Expires 2031-06-10 F1 · derivative.exercise_date: The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). Read SEC document |
| June 01, 2021 Filed Jun 8, 2021 17:03 UTC |
Priar Robert JChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001209191-21-038972 · doc4.xml · derivative · entry 1 Priar Robert J · CIK 0001864620 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2031-06-01 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest and become exercisable on June 1, 2022, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from June 1, 2022, subject to Reporting Person's Continuous Service (as defined in the Company's 2018 Equity Incentive Plan) through each such applicable vesting date and the terms of the Company's 2018 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.